osapiens raises $120M round led by Growth Equity at Goldman Sachs Alternatives
osapiens, an ESG platform offering compliance and sustainability reporting solutions, has secured $120 million in a Series B funding round led by Growth Equity at Goldman Sachs Alternatives.
The investment aims to support osapiens' global expansion and technological advancements, enhancing business compliance, resilience, and efficiency. Goldman Sachs Alternatives has acquired a minority stake in osapiens, joining Armira Growth, the lead investor of the $27M Series A in 2023.
osapiens has rapidly become a prominent player in the ESG technology sector. Its flagship product, the osapiens HUB, is an AI-powered cloud platform that streamlines compliance with international ESG regulations such as the Corporate Sustainability Reporting Directive (CSRD), the European Union Deforestation-free Regulation (EUDR), and the Corporate Sustainability Due Diligence Directive (CSDDD). The HUB also helps companies identify and mitigate risks in operations and supply chains, reducing manual workloads through process automation.
What sets osapiens apart is its ability to use a common data model to integrate multiple compliance, risk mitigation, and operational efficiency modules into one platform. This unique approach enhances transparency and efficiency, providing actionable insights that promote long-term sustainability and positive business impacts.
“We are thrilled to be working with Goldman Sachs,” said Alberto Zamora, Co-Founder and CEO of osapiens. “Their support is a testament to our leadership position in this highly competitive and rapidly evolving market – ESG compliance and process efficiency. We are proud to offer a single platform that helps companies around the world to navigate the complexities of ESG regulation with ease and confidence and to achieve long-term sustainability. osapiens enables them to make a positive impact not only on their P&L but also on the planet.”
Alexander Lippert, Managing Director in Growth Equity at Goldman Sachs Alternatives, said: “osapiens creates extraordinary value for their customers, helping them meet an increasing number of regulatory requirements, whilst simultaneously driving tangible business value. We see enormous potential in osapiens and we are pleased to help them further on their mission.”
